TAGLN2 and esophageal squamous cell carcinoma: Our data revealed that TAGLN2 knockdown or CRNN overexpression inhibited ESCC PDX tumor growth, leading to reduced tumor volume and tumor weight, without any adverse effects on the mice body weight (Fig. 8i–k, Supplementary Fig. 7c).